Abstracts tagged "muscle biopsy and vasculitis"

Abstract Number: 2944 • 2016 ACR/ARHP Annual Meeting
Use of Muscle Biopsies for the Diagnosis of Systemic Vasculitis in a Rheumatology Service
Samantha Rodriguez-Muguruza^1,2, Juana Sanint³, Xavier Saenz-Sarda⁴, Agueda Prior², Yaiza Garcia⁵, Maria Lourdes Mateo⁶, Susana Holgado⁶, Jeronima Cañellas², Melania Martínez-Morillo⁷, Xavier Tena⁶ and Alejandro Olivé¹, ¹Rheumatology, Hospital Universitario Germans Trias i Pujol, Barcelona, Spain, ²Rheumatology, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain, ³Rheumatology, Hospital Universitario Germans Trias i Pujol, Badalona, Spain, ⁴Anathomy Pathology, Germans Trias i Pujol Hospital, Barcelona, Spain, ⁵Rheumatology, Germans Trias i Pujol Hospital, Barcelona, Spain, ⁶Rheumatology, Hospital Germans Trias i Pujol, Badalona, Spain, ⁷Rheumatology, Germans Trias i Pujol University Hospital, Barcelona, Spain
Background/Purpose: Systemic vasculitis comprises a group of diseases characterized by non-infectious inflammation of vessels in various organs. Histopathological confirmation of systemic vasculitis is required for…
Abstract Number: 1762 • 2014 ACR/ARHP Annual Meeting
The Muscle Biopsy Is a Useful and Noninvasive Procedure in Diagnosing Systemic Vasculitis Affecting Small-to-Medium-Sized Vessels: A Prospective Evaluation
Takahiro Nunokawa¹, Takayasu Kise¹, Naoto Yokogawa², Kota Shimada¹ and Shoji Sugii², ¹Department of Rheumatic diseases, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan, ²Department of Rheumatic Diseases, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan
Background/Purpose: Histopathological confirmation is required for the diagnosis of systemic vasculitis. However, patients suspected of vasculitis often only have lesions with a low diagnostic yield…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].